Evidence map›Paper›PMID 26921940›Full record

ArticleMethods in enzymology2016

Study of Chemotaxis and Cell-Cell Interactions in Cancer with Microfluidic Devices.

Jiqing Sai, Matthew Rogers, Kathryn Hockemeyer, John P Wikswo, Ann Richmond

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Ex Vivo Model of Breast Cancer Cell Invasion in Live Lymph Node Tissue.ACS pharmacology & translational science · 2025
    Article
  4. Article
  5. Ex vivo model of breast cancer cell invasion in live lymph node tissue.bioRxiv : the preprint server for biology · 2024
    Article
  6. Motion Blur Microscopy.bioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. 3D cancer models: One step closer toFrontiers in immunology · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jiqing SaiDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA; Department of Cancer Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Matthew RogersVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee, USA.
Kathryn HockemeyerVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee, USA.
John P WikswoVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee, USA; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA; Department of Physics and Astronomy, Vanderbilt University, Nashville, Tennessee, USA.
Ann RichmondDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA; Department of Cancer Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee, USA; Vanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee, USA. Electronic address: ann.richmond@vanderbilt.edu.
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
MELANOMA GROWTH STIMULATORY ACTIVITYR01CA034590 · NCI · VANDERBILT UNIVERSITY · PI RICHMOND, ANN · 1986 to 2017
$5.2M
PI(3,4,5)P3 Regulates Cell Polarity During Chemotaxis and CytokinesisR01GM080370 · NIGMS · VANDERBILT UNIVERSITY · PI JANETOPOULOS, CHRISTOPHER J · 2008 to 2012
$1.4M
Modeling New Therapeutic Approaches for Malignant MelanomaI01BX002301 · VA · VETERANS HEALTH ADMINISTRATION · PI Julie A Rhoades (Sterling) · 2014 to 2026
–
BLRD VA I01 BX002301BLRD VA IK6 BX005225NCI NIH HHS CA68485NCI NIH HHS K12 CA090625NCI NIH HHS K12-CA90625NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA034590NCI NIH HHS R01 CA34590NIGMS NIH HHS R01 GM080370NIGMS NIH HHS R01GM080370
6 · The paper itself

Abstract

Microfluidic devices have very broad applications in biological assays from simple chemotaxis assays to much more complicated 3D bioreactors. In this chapter, we describe the design and methods for performing chemotaxis assays using simple microfluidic chemotaxis chambers. With these devices, using real-time video microscopy we can examine the chemotactic responses of neutrophil-like cells under conditions of varying gradient steepness or flow rate and then utilize software programs to calculate the speed and angles of cell migration as gradient steepness and flow are varied. Considering the shearing force generated on the cells by the constant flow that is required to produce and maintain a stable gradient, the trajectories of the cell migration will reflect the net result of both shear force generated by flow and the chemotactic force resulting from the chemokine gradient. Moreover, the effects of mutations in chemokine receptors or the presence of inhibitors of intracellular signals required for gradient sensing can be evaluated in real time. We also describe a method to monitor intracellular signals required for cells to alter cell polarity in response to an abrupt switch in gradient direction. Lastly, we demonstrate an in vitro method for studying the interactions of human cancer cells with human endothelial cells, fibroblasts, and leukocytes, as well as environmental chemokines and cytokines, using 3D microbioreactors that mimic the in vivo microenvironment.

Indexed as

ChemotaxisLab-On-A-Chip DevicesAnimalsCell CommunicationCell MovementCells, CulturedChemokinesEquipment DesignHL-60 CellsHumansMicrofluidic Analytical TechniquesMicrofluidicsNeoplasmsTumor MicroenvironmentChemokinesChemotaxisCXCR2Gradient switchMicrobioreactorMicrofluidic devicePolarizationTumor microenvironment

Identifiers

PMID26921940
PMCPMC5378165
OpenAlexW2223396731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.